Gene Therapy for Painful Diabetic Neuropathy



Status:Archived
Conditions:Diabetic Neuropathy, Neurology, Pain
Therapuetic Areas:Endocrinology, Musculoskeletal, Neurology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:February 2010
End Date:September 2011

Use our guide to learn which trials are right for you!

A Phase I/II, Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients With Painful Diabetic Peripheral Neuropathy


The purpose of this study is to assess the safety and tolerability of injecting VM202 in the
leg muscle in patients with painful diabetic neuropathy (DPN). The study will also assess
the potential of VM202 to reduce the pain associated with DPN.


Peripheral neuropathy is a serious complication of diabetes. This form of neuropathy
carries a high risk of pain, trophic changes and autonomic dysfunction.

Currently, there are no approved drugs or interventional strategies known to halt or reverse
the progression of DPN. Treatments target pain reduction, physical function improvement,
reduction of psychological distress, and quality of life improvements.

There is currently no effective treatment for diabetic neuropathy, and good glycemic control
is the only way to minimize the risk of occurrence. Clearly, it would be desirable to
prevent, impede, or reverse the disrupting and often life-threatening manifestations of
peripheral neuropathy by stimulating growth or regeneration of peripheral nerve axons.


We found this trial at
2
sites
201 East Huron Street
Chicago, Illinois 60611
(847) 491-3741
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Walnut Creek, California
?
mi
from
Walnut Creek, CA
Click here to add this to my saved trials